Epidiolex (CBD) in Patients With Biochemically Recurrent Prostate Cancer
Clinical trial NCT04428203 · COMPLETED
Trial details
- NCT number
- NCT04428203
- Sponsor
- Zin W Myint
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-03
- Primary completion
- 2021-08-20
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.